Transpek Industry Q1 FY27 results: net profit falls 43% YoY
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 4.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Transpek Industry's Q1 FY27 (quarter ended June 30, 2026) standalone revenue from operations stood at Rs 15,106 lakhs versus Rs 15,423 lakhs a year ago, down about 2 percent YoY. Total income was Rs 15,506 lakhs versus Rs 16,589 lakhs. Net profit dropped sharply to Rs 893 lakhs from Rs 1,558 lakhs, a fall of about 43 percent YoY. EPS came in at Rs 15.99 versus Rs 27.90. Auditor Bansi S Mehta and Co gave an unmodified review report. No exceptional items reported. Consolidated results include wholly owned subsidiary Transpek Creative Chemistry.
Sharp 43 percent YoY drop in net profit despite only modest revenue decline; weaker margins may weigh on the stock near term.